Alzheimer's Disease Clinical Trial
— cuiDemOfficial title:
Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres
An experimental study designed to test the effectiveness of a psychological intervention based on group therapy for the caregivers of Alzheimer's disease patients. The intervention consists of 16 sessions of a cognitive-behavioral psychological group therapy. This study aims to demonstrate that Alzheimer's patients' caregivers can decrease the feelings of burden after been involved in a group therapy.
Status | Completed |
Enrollment | 231 |
Est. completion date | September 2015 |
Est. primary completion date | July 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Main caregiver of an Alzheimer Disease Patient. - Alzheimer Disease Patient with mild/severe cognitive impairment. - High compliance to therapy sessions. - Sign informed consent. Exclusion Criteria: - Low commitment to develop all study phases. - Caregiver activity remunerated. - Caregiver with psychiatric disorders that can affect the development of the sessions. - Caregivers who have received psychological care during last year. |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Spain | AFA Barcelona | Barcelona | |
Spain | Centro de día Vitalia | Barcelona | |
Spain | AFA Burgos | Burgos | |
Spain | AFA Castellón | Castellón | |
Spain | AGUAFA | Guadasuar | |
Spain | AFA Lleida | Lleida | |
Spain | Centro de envejecimiento saludable | Málaga | |
Spain | Fundació Ana Ribot | Pallejà | |
Spain | AVAN | Sabadell | |
Spain | AFATE | Tenerife | |
Spain | AFA Terres de l'Ebre | Tortosa |
Lead Sponsor | Collaborator |
---|---|
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Efficacy of group therapy in caregiver burden measured by Zarit Burden Interview. | 16 months | No | |
Secondary | Change in caregiver burden from baseline compared to the control and active arms measured by Zarit Burden Interview. | 4 months and 16 months | No | |
Secondary | Change in anxiety and depression from baseline compared to the control and active arms measured by Goldberg Scale. | 4 months and 16 months | No | |
Secondary | Descriptive analysis of the caregivers' characteristics (sociodemographics, relation wih the AD patient). | Baseline (0 months) | No | |
Secondary | Descriptive analysis of the caregiver's cognition using DEM-DETECT Module 1. | 4 months | No | |
Secondary | Preliminary cost-effectiveness analysis related resources needed to caregivers and Alzheimer patients. | 4 months - 16 months | No | |
Secondary | Change in quality of life from baseline compared to the control and active arms measured by Casp-19 and SF-36 questionnaires. | 4 months - 16 months | No | |
Secondary | Change in resilience from baseline compared to the control and active arms measured by Connor-Davidson Resilience Scale. | 4 months - 16 months | No | |
Secondary | Change in functional social support from baseline compared to the control and active arms using Duke-UNC questionnaire. | 4 months - 16 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Withdrawn |
NCT03316898 -
A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
|
Phase 1 | |
Withdrawn |
NCT02860065 -
CPC-201 Alzheimer's Disease Type Dementia: PET Study
|
Phase 2 | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Recruiting |
NCT05607615 -
A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease
|
Phase 2 | |
Terminated |
NCT03307993 -
Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease
|
Phase 1 | |
Recruiting |
NCT02912936 -
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
|
N/A | |
Active, not recruiting |
NCT02899091 -
Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT02868905 -
Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women
|
N/A | |
Completed |
NCT02907567 -
Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease
|
Phase 1/Phase 2 | |
Terminated |
NCT02521558 -
Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease
|
N/A | |
Completed |
NCT02580305 -
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
|
Phase 2 | |
Completed |
NCT02516046 -
18F-AV-1451 Autopsy Study
|
Phase 3 | |
Recruiting |
NCT02247180 -
Cognitive Rehabilitation in Alzheimer`s Disease
|
N/A | |
Terminated |
NCT02220738 -
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
|
Phase 1 | |
Completed |
NCT02260167 -
Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol
|
N/A | |
Completed |
NCT02256306 -
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
|
N/A | |
Completed |
NCT02317523 -
Alzheimer's Caregiver Coping: Mental and Physical Health
|
N/A | |
Not yet recruiting |
NCT01940952 -
Zydena on Cognitive Function of Alzheimer's Disease Patients
|
Phase 3 |